VSIR and female reproductive system neoplasm: In this review, we summarize the structure, expression, and immunomodulatory mechanism of VISTA, and suggest the feasibility of VISTA as a new immune checkpoint for the immunotherapy of gynecological tumors, to improve the treatment status and prognosis of gynecologic oncology patients.